SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 16th, 2021 • Histogen Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 16th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of December 15, 2021, between Histogen Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 16th, 2021 • Histogen Inc. • Pharmaceutical preparations
Contract Type FiledDecember 16th, 2021 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of December 15, 2021, by and between Histogen Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT HISTOGEN INC.Placement Agent Common Stock Purchase Warrant • December 16th, 2021 • Histogen Inc. • Pharmaceutical preparations
Contract Type FiledDecember 16th, 2021 Company IndustryTHIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June 21, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on June 21, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Histogen Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain engagement letter, dated as of December 28, 2020, by and between the Company and H.C. Wainwright & Co., LLC, as amended on June 7, 2021.
COMMON STOCK PURCHASE WARRANT HISTOGEN INC.Common Stock Purchase Warrant • December 16th, 2021 • Histogen Inc. • Pharmaceutical preparations
Contract Type FiledDecember 16th, 2021 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after __________________[THE SIX MONTH ANNIVERSRAY OF THE ISSUE DATE + ONE DAY OF THE ISSUE DATE] (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________ (the “Termination Date”) but not thereafter, to subscribe for and purchase from Histogen Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).